SGLT2 knockout prevents hyperglycemia and is associated with reduced pancreatic β-cell death in genetically obese mice.
Journal Information
Full Title: Islets
Abbreviation: Islets
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosure of potential conflicts of interest Jean Whaley is currently an employee of Janssen Research and Development and a former employee of Bristol-Myers Squibb, where she contributed to the development of the SGLT2 inhibitor dapagliflozin. All other authors declare they have no competing interests."
"This work was supported by the National Institutes of Health [DK-099402 M.J.J.; DK-110181 and DK-092606 R.G.K] and Astrazeneca/Bristol-Myers Squibb."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025